Baxter International Inc. (0QK8.L)
0QK8.L Stock Price Chart
Explore Baxter International Inc. interactive price chart. Choose custom timeframes to analyze 0QK8.L price movements and trends.
0QK8.L Company Profile
Discover essential business fundamentals and corporate details for Baxter International Inc. (0QK8.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Equipment & Services
IPO Date
9 May 2014
Employees
38.00K
Website
https://www.baxter.comCEO
David Brent Shafer
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
0QK8.L Financial Timeline
Browse a chronological timeline of Baxter International Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 29 Apr 2026
Upcoming earnings on 18 Feb 2026
Upcoming earnings on 6 Nov 2025
Upcoming earnings on 4 Aug 2025
Revenue estimate is $2.82B.
Dividend declared on 30 May 2025
A dividend of $0.17 per share was announced, adjusted to $0.17. The dividend was paid on 1 Jul 2025.
Earnings released on 1 May 2025
EPS came in at $0.55 surpassing the estimated $0.48 by +13.75%, while revenue for the quarter reached $2.63B, missing expectations by -7.28%.
Dividend declared on 28 Feb 2025
A dividend of $0.17 per share was announced, adjusted to $0.17. The dividend was paid on 1 Apr 2025.
Earnings released on 20 Feb 2025
EPS came in at -$1.00 falling short of the estimated $0.53 by -289.77%, while revenue for the quarter reached $2.75B, beating expectations by +4.81%.
Dividend declared on 29 Nov 2024
A dividend of $0.17 per share was announced, adjusted to $0.17. The dividend was paid on 2 Jan 2025.
Earnings released on 8 Nov 2024
EPS came in at $0.49 falling short of the estimated $0.78 by -36.94%, while revenue for the quarter reached $2.70B, missing expectations by -29.83%.
Dividend declared on 30 Aug 2024
A dividend of $0.29 per share was announced, adjusted to $0.29. The dividend was paid on 1 Oct 2024.
Earnings released on 6 Aug 2024
EPS came in at -$0.62 falling short of the estimated $0.66 by -193.00%, while revenue for the quarter reached $3.81B, beating expectations by +1.52%.
Dividend declared on 31 May 2024
A dividend of $0.29 per share was announced, adjusted to $0.29. The dividend was paid on 1 Jul 2024.
Earnings released on 2 May 2024
EPS came in at $0.07 falling short of the estimated $0.61 by -88.05%, while revenue for the quarter reached $3.59B, beating expectations by +1.08%.
Earnings released on 5 Mar 2024
EPS came in at $0.50 falling short of the estimated $0.86 by -42.25%, while revenue for the quarter reached $3.89B, beating expectations by +2.07%.
Dividend declared on 29 Feb 2024
A dividend of $0.29 per share was announced, adjusted to $0.29. The dividend was paid on 1 Apr 2024.
Dividend declared on 30 Nov 2023
A dividend of $0.29 per share was announced, adjusted to $0.29. The dividend was paid on 2 Jan 2024.
Earnings released on 2 Nov 2023
EPS came in at -$0.75 falling short of the estimated $0.67 by -212.96%, while revenue for the quarter reached $3.71B, beating expectations by +0.29%.
Dividend declared on 31 Aug 2023
A dividend of $0.29 per share was announced, adjusted to $0.29. The dividend was paid on 2 Oct 2023.
Earnings released on 27 Jul 2023
EPS came in at -$0.28 falling short of the estimated $0.60 by -146.44%, while revenue for the quarter reached $3.71B, missing expectations by -2.07%.
Dividend declared on 1 Jun 2023
A dividend of $0.29 per share was announced, adjusted to $0.29. The dividend was paid on 3 Jul 2023.
Earnings released on 27 Apr 2023
EPS came in at $0.09 falling short of the estimated $0.49 by -82.42%, while revenue for the quarter reached $3.65B, beating expectations by +1.32%.
Dividend declared on 23 Feb 2023
A dividend of $0.29 per share was announced, adjusted to $0.29. The dividend was paid on 3 Apr 2023.
Earnings released on 9 Feb 2023
EPS came in at $0.36 falling short of the estimated $0.94 by -61.98%, while revenue for the quarter reached $3.89B, beating expectations by +3.18%.
Dividend declared on 1 Dec 2022
A dividend of $0.29 per share was announced, adjusted to $0.29. The dividend was paid on 3 Jan 2023.
Earnings released on 30 Sept 2022
EPS came in at -$5.83 falling short of the estimated $0.82 by -815.02%, while revenue for the quarter reached $3.77B, beating expectations by +0.19%.
Dividend declared on 1 Sept 2022
A dividend of $0.29 per share was announced, adjusted to $0.29. The dividend was paid on 3 Oct 2022.
Earnings released on 27 Jul 2022
EPS came in at $0.50 falling short of the estimated $0.87 by -43.24%, while revenue for the quarter reached $3.75B, missing expectations by -3.41%.
Dividend declared on 2 Jun 2022
A dividend of $0.29 per share was announced, adjusted to $0.29. The dividend was paid on 1 Jul 2022.
Earnings released on 27 Apr 2022
EPS came in at $0.14 falling short of the estimated $0.80 by -82.58%, while revenue for the quarter reached $3.71B, beating expectations by +0.79%.
Dividend declared on 24 Feb 2022
A dividend of $0.28 per share was announced, adjusted to $0.28. The dividend was paid on 1 Apr 2022.
Earnings released on 17 Feb 2022
EPS came in at $0.47 falling short of the estimated $1.03 by -54.43%, while revenue for the quarter reached $3.51B, beating expectations by +6.50%.
Dividend declared on 2 Dec 2021
A dividend of $0.28 per share was announced, adjusted to $0.28. The dividend was paid on 3 Jan 2022.
Earnings released on 28 Oct 2021
EPS came in at $0.59, while revenue for the quarter reached $3.10B.
Earnings released on 30 Sept 2021
EPS came in at $0.89, while revenue for the quarter reached $3.23B.
Dividend declared on 2 Sept 2021
A dividend of $0.28 per share was announced, adjusted to $0.28. The dividend was paid on 1 Oct 2021.
Dividend declared on 3 Jun 2021
A dividend of $0.28 per share was announced, adjusted to $0.28. The dividend was paid on 1 Jul 2021.
Earnings released on 31 Mar 2021
EPS came in at $0.58, while revenue for the quarter reached $2.95B.
Dividend declared on 25 Feb 2021
A dividend of $0.25 per share was announced, adjusted to $0.25. The dividend was paid on 1 Apr 2021.
Earnings released on 31 Dec 2020
EPS came in at $0.33, while revenue for the quarter reached $3.18B.
Dividend declared on 3 Dec 2020
A dividend of $0.25 per share was announced, adjusted to $0.25. The dividend was paid on 4 Jan 2021.
Earnings released on 30 Sept 2020
EPS came in at $0.69, while revenue for the quarter reached $2.97B.
Dividend declared on 28 Aug 2020
A dividend of $0.25 per share was announced, adjusted to $0.25. The dividend was paid on 1 Oct 2020.
0QK8.L Stock Performance
Access detailed 0QK8.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.